Found 52 matching trials
Prostate Cancer Biobank N/A Carcinoma of the prostate is the second most commonly diagnosed cancer and ...
Show More Status
Active Not Recruiting
Location
Kantonsspital Baden
Learn More & Join Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial PHASE2 This ComboMATCH patient screening trial is the gateway to a coordinated set...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors NA The goal of this clinical research trial is to study the use of differing i...
Show More Location
The New York Proton Center
Learn More & Join Trial
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. N/A Novel treatment modalities like targeted therapies and Immune checkpoint in...
Show More Location
European Institute of oncology
Learn More & Join Trial
Plan Development for Giving Teclistamab in the Outpatient Setting PHASE4 This is a pilot study to develop an outpatient-based process for the admini...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma PHASE2 MARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluat...
Show More Location
Ironwood Cancer and Research Center
Learn More & Join Trial
GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab PHASE1 The aim of this study is to investigate the safety and the clinical activit...
Show More Status
Active Not Recruiting
Location
CHRU BESANCON - Hopital Jean Minjoz
Learn More & Join Trial
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors PHASE1 This open-label, multicenter, Phase Ib dose-escalation study will evaluate ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib PHASE2 This is a multicenter, open-label phase 2 study that will enroll KRASG12C m...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer PHASE4 Given that pyrotinib has been proven to exert significant efficacy against ...
Show More Location
Peking University People's Hospital
Learn More & Join Trial